Chapter 462 - 270: World Influence
Chapter 462: Chapter 270: World Influence
’The controllable, adjustable self-expanding valve delivery system... This is destined to be a technological milestone in the history of Jin Country Heart Surgery, and my medical college’s team is fortunate enough to be part of it. What a source of pride!’
Dean Duan was in high spirits. In addition to inviting Professor Wu for a lecture, he decided Wu Ting’s appointment also needed to be revised.
He could absolutely offer Wu Ting a full professorship. If he had the authority, he would have even offered him the position of vice dean to bind him to the future of the Fan City University Medical College.
The history of many universities in Jin Country showed that their development was often spurred on by one or two powerhouses who carried them to new heights.
Dean Duan saw that same potential in Wu Ting.
...
...
In addition to his friends and partners in Fan City, several top international pharmaceutical companies had also taken notice of the national skills competition in Jin Country.
The Southern Country Johnson & Johnson Pharmaceutical Group had previously expressed interest in partnering with Wu’s Pharmaceutical Company to become the distributor for Wu Ting’s fourth-generation bioresorbable polymer vascular stent.
Now, with the debut of Wu Ting’s controllable, adjustable self-expanding valve delivery system and its application in clinical treatments, the top executives at Johnson & Johnson Pharmaceutical could no longer sit still.
Steve, the vice president of Southern Country Johnson & Johnson’s headquarters, prepared to travel to Jin Country to visit Wu Ting in person.
This time, Southern Country Johnson & Johnson was coming with the utmost sincerity.
The Johnson & Johnson Group and Ruihui were direct competitors. Wu Ting’s team and Ruihui were bitter rivals, and now they found themselves on opposing sides once again in the liver tumor field over Professor Edwards’s Neutrino Technology.
The core patent within the Neutrino Technology—the neutrino collider technology—was held by Pfizer.
Currently, Pfizer and Professor Edwards were joined at the hip, and they would never stand idly by and watch Wu Ting’s research project succeed. This made it highly unlikely for them to cooperate on the recent breakthrough in the field of heart surgery.
The Ruihui Group was also one of the financial backers of the *International Journal of Hepatobiliary and Pancreatic Diseases*. This meant that unless Ruihui completely abandoned Professor Edwards’s team and apologized to Wu Ting, there was no room for reconciliation.
The interests of the Ruihui Group, Professor Edwards, and the International Liver Cancer Association were too deeply intertwined.
And this was Johnson & Johnson’s opportunity. The Johnson & Johnson Group was preparing to bet on Wu Ting.
This time, they planned to partner with Wu Ting’s team to secure the exclusive distribution rights in the Mizhou District for the fourth-generation bioresorbable polymer vascular stent and the controllable, adjustable self-expanding valve delivery system.
To achieve this, they were willing to support and cooperate with Wu Ting’s team in certain areas!
In the field of liver tumors, it was anyone’s guess who would ultimately come out on top. However, in the cardiovascular field at least, Wu Ting’s team was in a league of its own.
In terms of overall market size, the patient population for cardiovascular diseases was far larger than that for liver tumors.
This was an irresistible temptation for Johnson & Johnson!
International organizations like the International Liver Cancer Association were backed and funded by pharmaceutical companies with their own complex web of interests.
The Ruihui Group was backing Professor Edwards and the International Liver Cancer Association.
So, the Johnson & Johnson Group would invest in Wu Ting’s team, betting on his future potential!
Although Wu Ting didn’t have enough influence yet, he was only twenty-eight years old!
Steve had a feeling that the Ruihui Group might just suffer a major setback at the hands of this doctor from Jin Country, Wu Ting!
...
...
「Yun Country. Lun City.」
GSK Group Headquarters.
Vice President Ford was also in a meeting with the company’s top executives.
After a detailed analysis and assessment, GSK had also formulated a strategic plan for the future.
Vice President Ford was preparing to travel to Jin Country to meet with Dr. Wu Ting in person.
They planned to secure the exclusive distribution rights in the Southern District for the fourth-generation bioresorbable polymer vascular stent and the controllable, adjustable self-expanding valve delivery system.
In addition, they were also prepared to covertly support Wu Ting’s team in their competition against Professor Edwards.
Apart from the International Liver Cancer Association, the Southern District had its own Southern Liver Research Association.
The financial backer behind this association was the GSK Group, with whom it was deeply intertwined.
This time, the Southern Liver Research Association would, at the opportune moment, lend Wu Ting a helping hand. This was also intended as a show of faith from GSK to Wu Ting’s team!
The ambitious Neutrino Technology from the Ruihui Group and Professor Edwards was putting immense pressure on the GSK Group.
If the Neutrino Technology were allowed to monopolize the field, and Professor Edwards’s International Liver Cancer Association went on to establish an international task force for HBV-related primary liver cancer, it was conceivable that all recommended drugs and related diagnostic equipment in the liver cancer sector would then be dominated by the Ruihui Group’s products.
This would be extremely disadvantageous for the GSK Group’s efforts to capture market share.
The enemy of my enemy is my friend.
Wu Ting’s team was still small at the moment, which was why Ford believed it was the perfect time to invest.
Ford had also spoken with Professor Bellingham, the director of the Liver Cancer Center at King’s College Hospital in Lun City—one of Yun Country’s top hospitals—who also served as the hospital’s vice dean.
Founded in 1840, King’s College Hospital had undergone 170 years of development to become a world-renowned, top-tier medical institution.
The hospital’s liver center was the largest and most comprehensive treatment center for liver diseases in the world (especially liver cancer). Furthermore, its liver transplant program was the largest in the Southern Continent.
Therefore, Professor Bellingham was a leading authority in the field of HBV-related liver cancer.
It was just that for years, Professor Edwards had always overshadowed him, and now he had launched the one-of-a-kind Neutrino Technology.
This was a major concern for Bellingham.
Bellingham was the president of the Southern Liver Research Association and the vice president of the International Liver Cancer Association, and he had been competing with Professor Edwards for the better part of his life.
Professor Bellingham had conducted in-depth research on Wu Ting’s papers and had also carefully studied his team’s research findings and the surgical data from their clinical procedures.
He was very optimistic about Wu Ting’s team’s diagnostic and treatment methods. Compared to the domineering and unscrupulous Professor Edwards, Professor Bellingham held a favorable view of the young Wu Ting.
At today’s annual meeting of the Southern Liver Research Association, Bellingham was planning to extend an invitation to Wu Ting to attend.
Bellingham was also very supportive of Ford’s trip to Jin Country to pursue in-depth collaboration with Wu Ting’s team.
If the first three phases of Wu Ting’s clinical trials for HBV-related primary liver cancer went smoothly, he would be more than willing to lend his full support!
Carrying the utmost sincerity, Ford headed for Xiao City.
...
...
「While the world outside was in an uproar, at Qinghe City Fuwai Hospital in Jin Country.」
The second half of the national heart surgery competition officially began.